The engineering of specific virus-targeting receptors onto a patient’s own immune cells is now being explored by scientists from Duke-NUS Medical School, as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2. This therapy that has revolutionised the treatment of patients with cancer has also been used in the treatment of other infectious diseases such as Hepatitis B virus, as discussed by the School’s researchers in a recent commentary.
- Predictive value of blood pressure, heart rate, and blood pressure/heart rate ratio in a Chinese subpopulation with vasovagal syncope
- Risk factors for intraoperative pressure injury in aortic surgery
- ECMO/CRRT in the treatment of critically ill SARS-CoV-2 pneumonia patients
- Regulating the ribosomal RNA production line
- New technique builds super-hard metals from nanoparticles